Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study.
Beatriz Barreto-DuarteKlauss Villalva-SerraJoão P Miguez-PintoMariana Araújo-PereiraVanessa M S CamposGabriela RosierBetânia M F NogueiraArtur T L QueirozValeria C RollaMarcelo Cordeiro-SantosAfrânio L KritskiLeonardo MartinezPeter F RebeiroTimothy R SterlingMoreno M RodriguesBruno Bezerril AndradePublished in: Open forum infectious diseases (2024)
Retreatment is a substantial risk factor for unfavorable ATT outcomes, especially after LTFU. The rates of treatment success in RLTFU are distant from the WHO End TB Strategy targets throughout Brazil. These findings underscore the need for targeted interventions to improve treatment adherence and outcomes in persons who experience RLTFU.